Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 65.6x - 72.5x | 69.0x |
| Selected Fwd P/E Multiple | 17.0x - 18.8x | 17.9x |
| Fair Value | ₺9.81 - ₺10.84 | ₺10.33 |
| Upside | -39.5% - -33.1% | -36.3% |
| Benchmarks | - | Full Ticker |
| Aksa Enerji Üretim A.S. | - | IBSE:AKSEN |
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | - | IBSE:CONSE |
| Mogan Enerji Yatirim Holding Anonim Sirketi | - | IBSE:MOGAN |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | - | IBSE:BIOEN |
| Galata Wind Enerji A.S. | - | IBSE:GWIND |
| Akfen Yenilenebilir Enerji | - | IBSE:AKFYE |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| AKSEN | CONSE | MOGAN | BIOEN | GWIND | AKFYE | |||
| IBSE:AKSEN | IBSE:CONSE | IBSE:MOGAN | IBSE:BIOEN | IBSE:GWIND | IBSE:AKFYE | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 43.6% | NM- | NM- | 77.0% | 67.0% | NM- | ||
| 3Y CAGR | 6.1% | 66.3% | NM- | 147.0% | 69.6% | -27.2% | ||
| Latest Twelve Months | -74.7% | -49.8% | -308.2% | -92.8% | -7.3% | -97.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 11.8% | 11.0% | -9.8% | 20.3% | 46.4% | 34.3% | ||
| Prior Fiscal Year | 15.6% | 17.7% | 9.9% | 42.5% | 33.5% | 104.3% | ||
| Latest Fiscal Year | 6.3% | 11.1% | -29.4% | 3.7% | 35.3% | 3.1% | ||
| Latest Twelve Months | 6.3% | 11.1% | -29.4% | 3.7% | 35.3% | 3.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 10.0x | 12.0x | 8.4x | 52.5x | 9.1x | 9.2x | ||
| Price / LTM Sales | 1.3x | 1.5x | 1.7x | 3.6x | 5.8x | 3.8x | ||
| LTM P/E Ratio | 21.0x | 13.4x | -5.6x | 98.0x | 16.4x | 123.3x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -5.6x | 16.4x | 98.0x | |||||
| Historical LTM P/E Ratio | -8.3x | 57.5x | 123.3x | |||||
| Selected P/E Multiple | 65.6x | 69.0x | 72.5x | |||||
| (x) LTM Net Income | 157 | 157 | 157 | |||||
| (=) Equity Value | 10,317 | 10,860 | 11,403 | |||||
| (/) Shares Outstanding | 1,197.0 | 1,197.0 | 1,197.0 | |||||
| Implied Value Range | 8.62 | 9.07 | 9.53 | |||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 8.62 | 9.07 | 9.53 | 16.21 | ||||
| Upside / (Downside) | -46.8% | -44.0% | -41.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | AKSEN | CONSE | MOGAN | BIOEN | GWIND | AKFYE | |
| Value of Common Equity | 42,186 | 2,028 | 21,375 | 9,665 | 13,651 | 19,403 | |
| (/) Shares Outstanding | 1,226.3 | 771.0 | 2,440.1 | 500.0 | 540.0 | 1,197.0 | |
| Implied Stock Price | 34.40 | 2.63 | 8.76 | 19.33 | 25.28 | 16.21 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 34.40 | 2.63 | 8.76 | 19.33 | 25.28 | 16.21 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |